KR20140126739A - 루판 트리테르페노이드 유도체 및 이의 약제학적 용도 - Google Patents
루판 트리테르페노이드 유도체 및 이의 약제학적 용도 Download PDFInfo
- Publication number
- KR20140126739A KR20140126739A KR1020147025188A KR20147025188A KR20140126739A KR 20140126739 A KR20140126739 A KR 20140126739A KR 1020147025188 A KR1020147025188 A KR 1020147025188A KR 20147025188 A KR20147025188 A KR 20147025188A KR 20140126739 A KR20140126739 A KR 20140126739A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- independently
- mmol
- optionally substituted
- alkyl
- Prior art date
Links
- 0 CC(C)C(*CC1(CC2)C(CC3*(*)(C4**(C)=C)C4C(CP)C3)I)=C1C(C)(CC1)[C@]2(C)C(C)(CCC(C2(C)C)C3(C)CCC2*(*)=C)[C@]13I Chemical compound CC(C)C(*CC1(CC2)C(CC3*(*)(C4**(C)=C)C4C(CP)C3)I)=C1C(C)(CC1)[C@]2(C)C(C)(CCC(C2(C)C)C3(C)CCC2*(*)=C)[C@]13I 0.000 description 9
- HJMBZQLCACVFEX-STOPFDMKSA-N CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(CC(C)(C)C(O)=O)O)[C@]13c1nnc(-c(cc2)ccc2[Tl])[s]1 Chemical compound CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(CC(C)(C)C(O)=O)O)[C@]13c1nnc(-c(cc2)ccc2[Tl])[s]1 HJMBZQLCACVFEX-STOPFDMKSA-N 0.000 description 1
- OSSBVKLFJNCTPE-KGMCRVEJSA-N CC(C)C(C(C1)=O)=C([C@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(CC(C)(C)C(O)=O)=O)[C@]13/C(/NC)=C(/C(CCCc(cc1)ccc1Cl)=O)\Cl Chemical compound CC(C)C(C(C1)=O)=C([C@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(CC(C)(C)C(O)=O)=O)[C@]13/C(/NC)=C(/C(CCCc(cc1)ccc1Cl)=O)\Cl OSSBVKLFJNCTPE-KGMCRVEJSA-N 0.000 description 1
- RZXMPPFPUUCRFN-UHFFFAOYSA-N Cc(cc1)ccc1N Chemical compound Cc(cc1)ccc1N RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210027090 | 2012-02-08 | ||
| CN201210027090.4 | 2012-02-08 | ||
| CN201310014849.XA CN103242413B (zh) | 2012-02-08 | 2013-01-15 | Lupane三萜系衍生物及其药学用途 |
| CN201310014849X | 2013-01-15 | ||
| PCT/CN2013/071100 WO2013117137A1 (en) | 2012-02-08 | 2013-01-30 | Lupane triterpenoid derivatives and pharmaceutical use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140126739A true KR20140126739A (ko) | 2014-10-31 |
Family
ID=48922317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147025188A KR20140126739A (ko) | 2012-02-08 | 2013-01-30 | 루판 트리테르페노이드 유도체 및 이의 약제학적 용도 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9428542B2 ( ) |
| EP (1) | EP2812343B1 ( ) |
| JP (1) | JP5872074B2 ( ) |
| KR (1) | KR20140126739A ( ) |
| CN (1) | CN103242413B ( ) |
| AU (1) | AU2013218441A1 ( ) |
| BR (1) | BR112014018953A8 ( ) |
| CA (1) | CA2860581A1 ( ) |
| EA (1) | EA201491479A1 ( ) |
| HK (1) | HK1202553A1 ( ) |
| WO (1) | WO2013117137A1 ( ) |
| ZA (1) | ZA201405819B ( ) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014105926A1 (en) | 2012-12-31 | 2014-07-03 | Hetero Research Foundation | Novel betulinic acid proline derivatives as hiv inhibitors |
| US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| EP3218387A1 (en) * | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | Oxolupene derivatives |
| WO2016077572A1 (en) * | 2014-11-14 | 2016-05-19 | Bristol-Myers Squibb Company | Extended betulinic acid analogs |
| EP3218388A1 (en) * | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | C17-aryl substituted betulinic acid analogs |
| MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
| WO2016147099A2 (en) | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
| WO2018029602A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-28 heterocycle derivatives as hiv inhibitors |
| WO2018029604A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors |
| WO2018029610A1 (en) * | 2016-08-09 | 2018-02-15 | Hetero Labs Limited | C-3 novel triterpenone with c-17 n-amide derivatives as hiv inhibitors |
| WO2018065930A1 (en) * | 2016-10-05 | 2018-04-12 | Hetero Labs Limited | C-3 triterpenone with c-17 reverse amide derivatives as hiv inhibitors |
| WO2018069857A1 (en) * | 2016-10-12 | 2018-04-19 | Hetero Labs Limited | C-3 novel triterpenone with c-17 reverse amide heterocycle derivatives as hiv inhibitors |
| WO2019150300A1 (en) | 2018-02-02 | 2019-08-08 | Glaxosmithkline Intellectual Property (No.2) Limited | Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid |
| PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
| CN114369134A (zh) * | 2020-10-15 | 2022-04-19 | 江西青峰药业有限公司 | 一种Lupane三萜系衍生物葡甲胺盐无定型物及其制备方法和应用 |
| CN115504947B (zh) * | 2022-08-23 | 2024-04-26 | 山东和源制药有限公司 | 一种呋喃酮酸的制备方法 |
| CN116041415B (zh) * | 2023-02-01 | 2023-08-18 | 吉林农业大学 | 一种裂环羽扇豆烷衍生物及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008127364A2 (en) * | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| AR063546A1 (es) * | 2006-11-03 | 2009-01-28 | Panacos Pharmaceuticals Inc | DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH. |
| WO2009073818A1 (en) * | 2007-12-04 | 2009-06-11 | Myriad Genetics, Inc. | Compounds and therapeutic use thereof |
| JP2011508748A (ja) * | 2008-01-03 | 2011-03-17 | バイロケム ファーマ インコーポレイテッド | 新規のルパン誘導体 |
| CN101977924A (zh) * | 2008-01-03 | 2011-02-16 | Viro化学制药公司 | 新的c-21-酮基羽扇烷衍生物、其制备方法和应用 |
| JP2013519674A (ja) | 2010-02-11 | 2013-05-30 | グラクソスミスクライン エルエルシー | ベツリンの誘導体 |
| JO3387B1 (ar) * | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
-
2013
- 2013-01-15 CN CN201310014849.XA patent/CN103242413B/zh active Active
- 2013-01-30 AU AU2013218441A patent/AU2013218441A1/en not_active Abandoned
- 2013-01-30 CA CA2860581A patent/CA2860581A1/en not_active Abandoned
- 2013-01-30 US US14/374,832 patent/US9428542B2/en not_active Expired - Fee Related
- 2013-01-30 EP EP13746137.2A patent/EP2812343B1/en active Active
- 2013-01-30 JP JP2014555064A patent/JP5872074B2/ja not_active Expired - Fee Related
- 2013-01-30 KR KR1020147025188A patent/KR20140126739A/ko not_active Application Discontinuation
- 2013-01-30 EA EA201491479A patent/EA201491479A1/ru unknown
- 2013-01-30 WO PCT/CN2013/071100 patent/WO2013117137A1/en active Application Filing
- 2013-01-30 BR BR112014018953A patent/BR112014018953A8/pt not_active IP Right Cessation
-
2014
- 2014-08-07 ZA ZA2014/05819A patent/ZA201405819B/en unknown
-
2015
- 2015-03-25 HK HK15103034.5A patent/HK1202553A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US9428542B2 (en) | 2016-08-30 |
| HK1202553A1 (en) | 2015-10-02 |
| AU2013218441A1 (en) | 2014-07-24 |
| CA2860581A1 (en) | 2013-08-15 |
| JP2015505545A (ja) | 2015-02-23 |
| WO2013117137A1 (en) | 2013-08-15 |
| CN103242413B (zh) | 2015-08-26 |
| EA201491479A1 (ru) | 2014-11-28 |
| EP2812343B1 (en) | 2019-03-13 |
| ZA201405819B (en) | 2015-12-23 |
| JP5872074B2 (ja) | 2016-03-01 |
| BR112014018953A8 (pt) | 2017-07-11 |
| CN103242413A (zh) | 2013-08-14 |
| EP2812343A1 (en) | 2014-12-17 |
| US20150011517A1 (en) | 2015-01-08 |
| BR112014018953A2 ( ) | 2017-06-20 |
| EP2812343A4 (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20140126739A (ko) | 루판 트리테르페노이드 유도체 및 이의 약제학적 용도 | |
| ES2940263T3 (es) | Compuestos químicos | |
| WO2021078301A1 (zh) | 蛋白降解剂及其在疾病治疗中的应用 | |
| EP3567035B1 (en) | N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer | |
| KR20240087636A (ko) | Kras g12d 억제제 및 이의 용도 | |
| ES2603262T3 (es) | Ácidos aminoindano-carboxílicos y aminotetralin-carboxílicos sustituidos y su uso | |
| WO2021027911A1 (zh) | 新型螺环类K-Ras G12C抑制剂 | |
| WO2023011513A1 (zh) | Shp2抑制剂、包含其的药物组合物及其用途 | |
| JP6091520B2 (ja) | ベツリンのプロペン酸誘導体 | |
| CN109956928B (zh) | 吡啶类化合物、其制备方法及用途 | |
| BR112014030284B1 (pt) | Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica | |
| AU2019272538B2 (en) | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | |
| CN115867556A (zh) | Lpa受体拮抗剂及其用途 | |
| CA2834417A1 (en) | Novel 3-hydroxyisothiazole 1-oxide derivative | |
| CN107207486A (zh) | 用于抑制布罗莫结构域和末端外蛋白质的方法和组合 | |
| CN112824420B (zh) | 用作egfr激酶抑制剂的化合物及其应用 | |
| WO2023198180A1 (zh) | Egfr降解剂 | |
| CA3152512A1 (en) | Perk inhibiting compounds | |
| JP2023054360A (ja) | 高カリウム血症を処置するためのグリチルレチン酸誘導体 | |
| WO2017173960A1 (zh) | 一类抑制丙肝病毒的大环状杂环化合物及其制备和用途 | |
| CN107074876B (zh) | 一类抑制丙肝病毒的大环状杂环化合物及其制备和用途 | |
| JP2024153692A (ja) | スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体 | |
| CN118076592A (zh) | Shp2抑制剂、包含其的药物组合物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |